معرفی
Cem Demirkiran is a Postdoctoral Associate at the Yale School of Medicine, affiliated with the Department of Obstetrics, Gynecology & Reproductive Sciences. His research focuses on Gynecologic Oncology and Translational Medicine, particularly investigating molecular mechanisms and targeted therapies in endometrial cancers and uterine serous carcinoma.
- Collaborators: Alessandro Santin, Stefania Bellone, Yang Yang, Mitchell Clark, Gloria Huang, Natalia Buza
- Recent Research: Preclinical evaluation of antibody-drug conjugates (e.g., datopotamab deruxtecan), genomic drivers (MAP2K4, ATRX), and clinical implementation of circulating tumor DNA biomarkers.
His work has been published in journals including Gynecologic Oncology, Cancer Research Communications, and Molecular Cancer Therapeutics, with a focus on improving treatment response monitoring and developing precision therapies for chemotherapy-resistant gynecologic malignancies.
۰مقاله منتشرشده